Home / Products / Cancer (Tumor) Cell Lines / NCI-H508
NCI-H508
Datasheet Protocol

NCI-H508

Cat. No. ARC0641
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Cecum

Growth Properties:

Adherent and suspension

In stock
$1,300.00 / Vial
Ask a Question

Short Description 🔒

NCI-H508 is a cancer cell line of cecum adenocarcinoma, isolated from metastatic; abdominal wall.

Recommended Products

BTN3A1 Knockout HAP1 Polyclonal Cells BTN3A1 Knockout HAP1 Polyclonal Cells Cat. No. ARG22151 ERGIC3 Knockout NCI-H1975 Polyclonal Cells ERGIC3 Knockout NCI-H1975 Polyclonal Cells Cat. No. ARG16942 ADARB1 Knockout K562 Polyclonal Cells ADARB1 Knockout K562 Polyclonal Cells Cat. No. ARG20008 ACSS2 Knockout jurkat Polyclonal Cells ACSS2 Knockout jurkat Polyclonal Cells Cat. No. ARG33734 CCDC90B Knockout A2780 Polyclonal Cells CCDC90B Knockout A2780 Polyclonal Cells Cat. No. ARG43105 NBEA Knockout Hela Polyclonal Cells NBEA Knockout Hela Polyclonal Cells Cat. No. ARG7858
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Cecum
Disease:
Adenocarcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent and suspension
Age:
55 years
Sex of Donor:
Male
Derived From Site:
Metastatic; Abdominal wall
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

NEXN Knockout NCI-H1975 Polyclonal Cells

NEXN Knockout NCI-H1975 Polyclonal Cells

Cat. No. ARG16634
 FLT3 Knockout Hela Polyclonal Cells

FLT3 Knockout Hela Polyclonal Cells

Cat. No. ARG8789
 ADAM17 Knockout HEK293T Polyclonal Cells

ADAM17 Knockout HEK293T Polyclonal Cells

Cat. No. ARG25603
 BZW2 Knockout HAP1 Polyclonal Cells

BZW2 Knockout HAP1 Polyclonal Cells

Cat. No. ARG27423
 ENG Knockout CaSki Polyclonal Cells

ENG Knockout CaSki Polyclonal Cells

Cat. No. ARG9882
 FARP1 Knockout AGS Polyclonal Cells

FARP1 Knockout AGS Polyclonal Cells

Cat. No. ARG2501